miRNA-based therapeutics for human cancer: miRNA-200a regulates widespread miRNA biogenesis via down regulation of its target gene, 27/May/2014, 5.44 am

Therapeutic insights into the treatment of Mammary, ovarian, renal & liver cancers : Tumor suppressor P53 increases the expression of BDGI via up regulation of its target gene, 27/May/2014, 5.33 am
May 27, 2014
Molecular mechanisms of tumorigenesis: N-Methyl-N’-Nitro-N-Nitrosoguanidine (MNNG) suppresses the expression of tumor suppressor TIMP3 via up regulation of its target gene, 27/May/2014, 6.02 am
May 27, 2014
Show all

Profs. Drs. R I Gregory, Camargo FD and their co-workers from Boston Children’s Hospital, MA, USA; Department of Biological Chemistry and Molecular Pharmacology and Department of Pediatrics, Harvard Medical School, Boston, MA, USA; and Harvard Stem Cell InstituteBoston, MA, USA had reported in the prestigious journal Cell (Feb 27, 2014) that Hippo Signaling Regulates Microprocessor and Links Cell-Density-Dependent miRNA Biogenesis to Cancer”  

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: miRNA-based therapeutics for human cancer: miRNA-200a regulates widespread miRNA biogenesis via down regulation of its target gene.

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, L, miRNA-based therapeutics for human cancer: miRNA-200a regulates widespread miRNA biogenesis via down regulation of its target gene.27/May/2014, 5.48 am

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Comments are closed.